Filing Flows › Ideaya Biosciences (IDYA) › R&D spending
Ideaya Biosciences (IDYA) R&D spending by quarter
Ideaya Biosciences' R&D spending was $122M in Q3 2026 (third quarter 2026), +12% from Q2 2026. Over the last 6 quarters it ranged from $83.0M (Q3 2025) to $140M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $122M | +12% | +46% |
| Q2 2026 | $109M | +14% | — |
| Q1 2026 | $95.7M | +11% | — |
| Q4 2025 | $86.6M | +4% | -38% |
| Q3 2025 | $83.0M | -41% | — |
| Q4 2024 | $140M | — | — |
Q3 2026 at a glance
Ideaya Biosciences, Q3 2026: revenue $10.2M (-95% year over year), net loss $126M, operating cash flow −$93.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ideaya Biosciences' R&D spending?
Ideaya Biosciences' R&D spending was $122M in Q3 2026 (third quarter 2026), +12% from Q2 2026.
How has Ideaya Biosciences' R&D spending changed?
Over the last 6 quarters it ranged from $83.0M (Q3 2025) to $140M (Q4 2024).